Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-transplantation of MSC and HLA-mismatched Allogeneic HSC After Nonmyeloablative Conditioning
NCT01045382Phase 2Terminated
- Sponsor
- University of Liège
- Start
- Jul 2010
- Primary completion
- Aug 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), sponsored by University of Liège. Started Jul 2010; status: terminated.
02
Drugs
mesenchymal stem cells
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)myeloproliferative neoplasms (MPN)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01045382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045382.